C4 Therapeutics (CCCC) Leases: 2019-2025
Historic Leases for C4 Therapeutics (CCCC) over the last 5 years, with Sep 2025 value amounting to $42.0 million.
- C4 Therapeutics' Leases fell 29.08% to $42.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.0 million, marking a year-over-year decrease of 29.08%. This contributed to the annual value of $57.5 million for FY2024, which is 10.04% down from last year.
- According to the latest figures from Q3 2025, C4 Therapeutics' Leases is $42.0 million, which was down 22.61% from $54.2 million recorded in Q2 2025.
- In the past 5 years, C4 Therapeutics' Leases ranged from a high of $74.8 million in Q1 2022 and a low of $12.2 million during Q3 2021.
- Moreover, its 3-year median value for Leases was $60.8 million (2024), whereas its average is $59.7 million.
- Per our database at Business Quant, C4 Therapeutics' Leases skyrocketed by 484.68% in 2022 and then dropped by 29.08% in 2025.
- Quarterly analysis of 5 years shows C4 Therapeutics' Leases stood at $31.9 million in 2021, then spiked by 119.49% to $70.1 million in 2022, then declined by 8.79% to $64.0 million in 2023, then fell by 10.04% to $57.5 million in 2024, then fell by 29.08% to $42.0 million in 2025.
- Its Leases was $42.0 million in Q3 2025, compared to $54.2 million in Q2 2025 and $55.9 million in Q1 2025.